Topic
PCSK9 inhibitor
FDA approves Lipfendra as first oral PCSK9 inhibitor for high cholesterol
Merck’s Lipfendra has received FDA approval as the first oral PCSK9 inhibitor, offering a daily pill option to help lower LDL cholesterol levels.